GlassScriptPhysician profile
Surendra K Purohit
NPI 1265506703
$3,059.22
in general payments reported to CMS, 2019-2025
42 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $493 · 2021: $556 · 2022: $109 · 2023: $334 · 2024: $294 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $532.44 | 2019-2022 | |
| Intuitive Surgical, INC. | $446.41 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $379.52 | 2019-2025 | |
| Urogen Pharma, INC. | $258.62 | 2024-2025 | |
| Antares Pharma, INC. | $168.02 | 2019-2025 | Xyosted |
| Coloplast Corp | $124.36 | 2019-2025 | Titan |
| Novo Nordisk INC | $115.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Davol INC. | $81.35 | 2019 | |
| Clarus Therapeutics INC. | $74.97 | 2021 | |
| Boston Scientific Corporation | $73.34 | 2023-2024 | Rezum Generator |
| Pfizer INC. | $72.94 | 2019-2020 | |
| Blue Earth Diagnostics | $54.55 | 2020-2021 | |
| Axonics, INC. | $48.49 | 2021-2024 | Bulkamid |
| Laborie Medical Technologies Corp. | $46.35 | 2025 | |
| Tolmar, INC. | $43.99 | 2024-2025 | Eligard, Jatenzo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $41.36 | 2023 | Bard Urinary Drainage Bag, Bardex I.C. Criticore Foley Tray Bardex Temperature-Sensing Foley Catheter |
| 180 Medical, INC. | $39.80 | 2023 | Gentlecath Glide, Cure Ultra Catheter |
| Glaxosmithkline, LLC. | $38.89 | 2022-2023 | Trelegy Ellipta |
| Civco Medical Instruments | $38.28 | 2024 | |
| Myriad Genetic Laboratories, INC. | $34.58 | 2021-2023 | Prolaris |
| Endogastric Solutions, INC | $28.26 | 2023 | Esophyx |
| Janssen Biotech, INC. | $22.10 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $20.57 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.42 | 2023 | Exparel |
| Ethicon US, LLC | $19.87 | 2019 | |
| Olympus America INC. | $19.14 | 2024 | Itind System |
| Tela Bio, INC. | $18.88 | 2024 | Ovitex 2s |
| Esperion Therapeutics, INC. | $17.94 | 2021 | |
| Becton, Dickinson and Company | $17.22 | 2023 | Phasix Mesh |
| Medtronic USA, INC. | $15.48 | 2020 | |
| Mission Pharmacal Company | $14.77 | 2021 | |
| Amgen INC. | $14.77 | 2023 | Otezla, Repatha |
| Baudax Bio INC. | $14.40 | 2020 | |
| Acerus Pharmaceuticals Corporation | $14.21 | 2021 | |
| Photocure INC | $14.16 | 2024 | Cysview |
| Merck Sharp & Dohme LLC | $14.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.53 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.38 | 2020 | |
| Teleflex LLC | $11.10 | 2021 | |
| Melinta Therapeutics, LLC | $10.92 | 2019 | |
| Sumitomo Pharma America, INC. | $7.84 | 2023 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $5.41 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surendra Purohit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.